(E) | 1. | ¤Æ¾ÇªvÀøÃĪ«¬Û¹ïÀ³ªº°Æ§@¥Î¡A¤U¦C°t¹ï¦óªÌ¿ù»~¡H |
A. | Paclitaxel: peripheral neuropathy |
B. | Bleomycin: pulmonary toxicity |
C. | Fluorouracil: hand-foot syndrome |
D. | Cisplatin: ototoxicity |
E. | Mitoxantrone: hemolytic-uremic syndrome |
|
(B) | 2. | ¦³Ãö¸~½FªþÄݯgÔ¸s(paraneoplastic syndrome)¡A¤U¦C±Ôz¦óªÌ¿ù»~¡H |
A. | ±`»P¸~½F²ÓM¤£·í¤Àªc¦hÐ`úT²üº¸»X(polypeptide hormone)¦³Ãö |
B. | GÀù¬O¤Þµoectopic ACTH syndrome¤¤³Ì±`¨£ªºì¦] |
C. | µÇ²ÓMÀù»Perythrocytosis¦³Ãö |
D. | ¤p²ÓMªÍÀù»PLambert-Eaton myasthenic syndrome¦³Ãö |
E. | ¸¢Àù¥i¤Þ°_Äjº©©Ê¦åºÞ¤º¦å²G¾®©T¯g(disseminated intravascular coagulation) |
|
(A) | 3. | 56·³¨k©Ê¯f¤H¡A¦]«K¦å¤ÎÅé«´î»´´NÂå¡A¤j¸zÃèÀˬdµo²{ª½¸z¤º¦³¤@2 cm¤§¸~¶ô¡A¸g¤Á¤ùÃҹꬰadenocarcinoma¡A¤U¦C±Ôz¦óªÌ¿ù»~¡H |
A. | Y¦P®Éµo²{¨xŦ¤º¦³Âಾ©Ê¯f¨_¡AÀ³¶i¦æ¥þ¨©Ê¤Æ¾ÇªvÀø¡A¤£¶·¦Ò¼{¤â³N |
B. | ¥þ¨©ÊÀˬd¡AYµL¨ä¥LÂಾ©Ê¯f¨_¡AÀ³¹ê¬I¤â³N¤Á°£ |
C. | YÃҹꬰDuke B2 or C¤§ª½¸zÀù¡AÀ³¦X¨Ö³N«á¤Æ¾ÇªvÀø©M§½³¡©ñ®g½uªvÀø |
D. | Y¥u¦³³æ¤@ªÍ³¡Âಾ©Ê¯f¨_¡A¨Ã¥i¤â³N¤Á°£¡A«h¤Á°£«á¤´¦³ªø´Á¦s¬¡ªº¾÷·| |
E. | ¹ï©ó´_µo©ÎÂಾ¤§ª½¸zÀù¡AY¿ï¾Ü¤Æ¾ÇªvÀø¡AÀ³¦Ò¼{5-fluorouracil¬°¥D¤§ªvÀø |
|
(C) | 4. | 52·³«D¤p²ÓMªÍÀù¤§¯f¤H¦]·NÃÑ»Ùê¡A³Q®a¤H°e¨ì«æ¶E´NÂå¡A¦å²GÀˬdÅã¥Ü calcium: 3.8 mmol/L¡A¤U¦C±Ôz¦óªÌ¿ù»~¡H |
A. | ¤j¶q¸É¥R¥Í²z¹ÆQ¤ô¡A¨ÃÀH®É°»´ú¦å¤¤¶tÂ÷¤l¿@«× |
B. | ¥i¦Ò¼{¨Ï¥ÎbisphosphonatesªvÀø |
C. | ¥i¯à»P¸~½F¤ÀªcªºPTH (parathyroid hormone) ¦³Ãö |
D. | «æ©Ê´Á¥i¦Ò¼{¨Ï¥ÎcalcitoninªvÀø |
E. | ¥i¯à»P¸~½FÂಾ¦Ü°©ÀY¦³Ãö |
|
(B) | 5. | 48·³¤k©Ê¯f¤H¡A¤T¦~«e¦]¥k°¼¨ÅÀù¡A±µ¨ü¨Å©Ð®Ú°£¤â³N¡C¸~½F¤§°Ê±¡¿E¯À±µ¨üÅé (estrogen receptor) ¬°¶§©Ê¡C¯f¤H¥¼±µ¨ü¥ô¦ó»²§U©ÊªvÀø¡C³Ìªñ¦]¤UI³¡¯kµh´NÂå¡A¥þ¨Àˬd°£¸y´Õ¦³Âಾ¤§¯f¨_¥~¡A¨ä¥L¨ÃµLÂಾ¡C¤U¦C±Ôz¦óªÌ¿ù»~¡H |
A. | ¥i¦Ò¼{²üº¸»XªvÀø |
B. | Y²üº¸»XªvÀø¯f±¡±o¨ì½w¸Ñ¡A¦ý¤@¬q®É¶¡«á¦A´c¤Æ¡A¦A¨Ï¥Î²Ä¤G½u²üº¸»XªvÀø³q±`µL®Ä |
C. | Y¦X¨Ö¨ä¥LÂಾ¤§¯f¨_¨Ã¦³¥ß§Y¥Í©R¦MÀI¡AÀ³¦Ò¼{¤Æ¾ÇªvÀø |
D. | Y¸y´Õµo¥Í¯f²z©Ê°©§é¡A¥i¦Ò¼{¤â³N©T©w |
E. | Y°©ÀY¯kµh«ùÄò¡A¥i¦Ò¼{½w¸Ñ©Ê§½³¡©ñ®g½uªvÀø |
|
(A) | 6. | 22·³¨k©Ê¦]¯Ýµh¤Î©I§l§xÃø¦Ü«æ¶E³B¡A¯Ý³¡X¥úÅã¥Ü«eÁa»JµÄ¦³¤@ 6x4 cm¤§¸~¶ô¡A¤Á¤ùÃҹꬰ¤À¤Æ¤£¨}©ÊÀù¯g(poorly-differentiated carcinoma)¡C¤U¦C±Ôz¦óªÌ¿ù»~¡H |
A. | ¤£¶·¶i¤@¨B¶i¦æ¸A¤Y¤§²z¾ÇÀˬd©Î¶WµªiÀˬd |
B. | ¥i¯à»P chromosome 12 ²§±`¦³Ãö |
C. | ¦å²GÀˬd¡G£\-FP or £]-hCG¥iÀ°§UŲ§O¶EÂ_ |
D. | À³§ë¤©cisplatin¬°¥Dªº¥þ¨©Ê¤Æ¾ÇªvÀø |
E. | ¤Æ¾ÇªvÀø«á¡AY¸~½F¼Ð°O«ì´_¥¿±`¡A¦ý¼v¹³Àˬd¤´¦³³Ñ¾l¸~½F®É¡A¥i¦Ò¼{¤â³N¤Á°£ |
|
(D) | 7. | ¤U¦C¦³ÃöG¤Î¤p¸z²O¤Ú½Fªº±Ôz¡A¦óªÌ¿ù»~¡H |
A. | Mucosa-associated lymphoid tissue lymphoma (MALToma) of stomach »P H. pylori ·P¬V¦³Ãö |
B. | Immunoproliferative small intestinal disease (IPSID)¡A±`¦³¸¡Âm©MÀç¾i¤£¨}¤§¯gª¬ |
C. | ¤j¦h¬O B-cell ¨Ó·½ |
D. | §Ü¥Í¯À¨Ã¤£¯à¥Î¨ÓªvÀø MALToma or IPSID |
E. | °ª´c©Ê«×(high-grade)¤§G¤Î¤p¸z²O¤Ú½F¡AÀ³§ë¤©¥þ¨©Ê¤Æ¾ÇªvÀø |
|
(D) | 8. | ¤U¦C¦³Ãö¸~½F¼Ð°O¬Û¹ïÀ³ªºÀù¯g¡A¦óªÌ¿ù»~¡H |
A. | PSA: prostate cancer |
B. | Calcitonin: medullary cancer of the thyroid |
C. | CEA: colon, breast or lung cancer |
D. | CA-125: pancreatic cancer or cholangiocarcinoma |
E. | Alpha-fetoprotein: hepatocellular carcinoma or germ cell tumor |
|
(C) | 9. | 52·³°±¸g¤k©Ê¡A¤¦~«e±µ¨ü¥k°¼¨Å©Ð¤Á°£¡A¯f²zÃҹꬰinfiltrating ductal carcinoma¡A°Ê±¡¿E¯À±µ¨üÅé(estrogen receptor)¬°¶§©Ê¡AµLµÅ¤U²O¤Úµ²«I¥Ç¡A³N«á¨Ã¥¼±µ¨ü¥ô¦ó»²§U©ÊªvÀø¡C¦¹¦¸¦]¥k¤j»L¯kµh¨Ã¼vÅT¦æ¨«¡A¬G¦Ü«æ¶E´NÂå¡A¢æ¥úÅã¥Ü¥k»ë°©ÀV³¡(femoral neck)¦³¤@3.5 cmª½®|¤§»k°©©Ê¯f¨_¡C¥þ¨©Ê¼v¹³Àˬd¨Ã¥¼µo²{¦³¨ä¥¦¤§Âಾ¡C¤U¦CªvÀø¡A¦óªÌ³Ì¾A©y1. Tamoxifen2. ¤Æ¾ÇªvÀø3. ©ñ®g½uªvÀø4. ¹w¨¾©Ê°©ÀY©T©w5. §Z±_¤Á°£ |
A. | 1, 2 |
B. | 1, 2, 3 |
C. | 1, 3, 4 |
D. | 3, 5 |
E. | 2, 3, 4 |
|
(D) | 10. | ¤U¦C¦óºØÀù¯g¤´¨S¦³¤½»{¦³®Ä(©µªø¯f¤HÁ`¦s¬¡²v)¤§¤â³N«á»²§U©Ê¤Æ¾ÇªvÀø(adjuvant chemotherapy)¡H1. ¨ÅÀù¨Ö¦P°¼µÅ¤U²O¤Úµ²Âಾ2. GÀù¨Ö§½³¡²O¤Úµ²Âಾ3. «Dºë²ÓM¥Í´Þ²ÓMÀù(Nonseminomatous germ cell tumor)¨Öª½®|¤j©ó5¤½¤À¤§«á¸¡µÄ²O¤Úµ²Âಾ4. °©·½©Ê¦×½F(Osteogenic sarcoma)5. µÇ²ÓMÀù(Renal cell carcinoma) |
A. | 2, 4, 5 |
B. | 3, 5 |
C. | 1, 2, 5 |
D. | 2, 5 |
E. | 2, 3, 5 |
|